UMARY ACID HYALURONIC recalled over undeclared diclofenac

Recall date

November 14, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

MXBBB recalls UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

Recall number

D-0166-2025

FDA classification

Class II

Brand / firm

MXBBB

Sold / distributed

Product was sold via Amazon Marketplace.

Why it was recalled

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323